Combined high-dose delta1-testololactone with low-dose 5-fluorouracil in the treatment of metastatic breast cancer.

Previous attempts to reduce toxicity of 5-fiuorouracil (5-FU) by lowering the dose and omitting loading have yielded low regression rates. We attempted to increase efficacy without increasing toxicity